A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
about
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.Cannabinoid receptor with an 'identity crisis' gets a second lookTreatment with a cannabinoid receptor 2 agonist decreases severity of established cystitisRole of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potencyAlcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic PotentialsMitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in miceProlonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.Activation of cannabinoid receptor 2 inhibits experimental cystitisEndocannabinoids in cerebrovascular regulation.Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeabilitySelective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrierApoptosis and necrosis in the liverCannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes.Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis.Isovolemic hemodilution with glutaraldehyde-polymerized human placenta hemoglobin (PolyPHb) attenuated rat liver ischemia/reperfusion injury.Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation.Early phytocannabinoid chemistry to endocannabinoids and beyond.LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamidePhosphorylation of extracellular signal-regulated kinase as a biomarker for cannabinoid receptor 2 activation
P2860
Q27303034-B0699AB6-AC9B-4642-83E4-97DBBB86D299Q29397935-9830D75C-B611-4608-B174-D7029A24A9A3Q34176058-5EB03F24-D7F2-4C8B-A710-F08D2A4CA056Q34545007-EFF1CD10-7B0A-4142-9BB5-7CA2A89EA6EAQ35854652-E021D5CF-F13C-4512-9C13-B72EAEFB5C2DQ35865677-EE4674D5-9FED-422A-98FA-2E45EB08F6AFQ36165438-997014BB-9F0D-4104-9D74-FC5079F898C0Q36203242-EDC04035-B083-46FD-A69A-F404BDAEC8EFQ36346915-94B7B596-DF20-4299-8BE5-A1BA6FAF2367Q36718218-D34403D4-E7DF-42AB-9AD3-FD022FA23489Q36799355-322E7EC9-44DA-4C3A-8E52-1137716535B5Q36838206-F44E3607-B56C-4482-99C9-B3A6FF3F79C5Q36895795-1D656BEF-DB35-4BA4-93F0-D75907F67AC1Q37148310-00DE95EE-48E9-4809-BCA5-990426462426Q37271987-C09EC838-EA6F-4C9D-84E3-CACEE68B4706Q37403072-5F986EA9-62AF-48CF-AEEF-F80AAFCAB343Q37562428-8427DF17-D398-4E52-A63D-DE779E5F7EC7Q38220272-50502A62-CA1D-47F2-B5CD-BB943E2F9131Q38455748-267658E6-2E9F-49FC-B3CF-190FD7A3B7A5Q38684679-1D2AEA00-0DFB-4A0F-B173-5000CA4EDD7EQ39524238-CA7BC063-34CA-4A43-9486-A2118044AE7FQ42110787-F42EC56E-EC9B-4158-BFD2-974D12999971Q42455586-D57C73F2-A39D-45AB-BC46-7F0CDD256CB3Q47785435-2E397F52-850E-4A09-B625-C58A8C1941D3Q48062717-0BECF3CD-D6FE-436D-881F-B75F5775BA2EQ48178388-8237A1B5-C9D8-4391-8891-60523A26FD77Q48347782-A4E23ABB-F869-43EB-B167-FCC9B9D896C5Q50116595-ED22126A-D85C-4633-9782-A2E319AFA8F5Q57729876-4DF3E739-60AA-4C5D-9C92-700C742642F2Q59132024-55EC7116-2315-4C52-8D71-677599C07585
P2860
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@ast
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@en
type
label
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@ast
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@en
prefLabel
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@ast
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@en
P2093
P2860
P50
P921
P1476
A new cannabinoid CB2 receptor ...... c ischaemia/reperfusion injury
@en
P2093
Bėla Horváth
Catherine E Goodfellow
Galin Tanchian
Lital Magid
Mohanraj Rajesh
Rachel Y Gao
Sándor Bátkai
P2860
P304
P356
10.1111/J.1476-5381.2011.01381.X
P407
P577
2012-04-01T00:00:00Z